Concepedia

Martin Škandík

MŠ

Statistics

Publications

4

Citations

104

H-Index

4

Active since

2015

Affiliations

Institute of Experimental Pharmacology and Toxicology of the Slovak Academy of Sciences(Current)

Slovak Academy of Sciences

Karolinska Institutet

Martin Škandík is an author at Institute of Experimental Pharmacology and Toxicology of the Slovak Academy of Sciences specializing in neuroimmunology, neuroinflammation, and neuroprotection.

ORCID

Top concepts

Publications per year

2015–2025

4

Publications

4

Modulation of BV-2 microglia functions by novel quercetin pivaloyl ester

Nataša Mrvová, Martin Škandík, Marcela Kuniaková et al. · Neurochemistry International · 2015 · 48 citations

, , +9

Semisynthetic quercetin-quinone mitigates BV-2 microglia activation through modulation of Nrf2 pathway

Martin Škandík, Nataša Mrvová, S Bezek et al. · Free Radical Biology and Medicine · 2020 · 32 citations

, , +8

Proteome integral solubility alteration high-throughput proteomics assay identifies Collectin-12 as a non-apoptotic microglial caspase-3 substrate

Kathleen Grabert, Pinelopi Engskog‐Vlachos, Martin Škandík et al. · Cell Death and Disease · 2023 · 12 citations · Full text

Age-associated microglial transcriptome leads to diminished immunogenicity and dysregulation of MCT4 and P2RY12/P2RY13 related functions

Martin Škandík, Guillermo Vázquez-Cabrera, Lily Keane et al. · Cell Death Discovery · 2025 · 12 citations · Full text

Rows per page

1–4 of 4